11-121130065-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005422.4(TECTA):​c.2795T>C​(p.Val932Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 1,613,878 control chromosomes in the GnomAD database, including 39,283 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V932L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.20 ( 3231 hom., cov: 33)
Exomes 𝑓: 0.22 ( 36052 hom. )

Consequence

TECTA
NM_005422.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.04

Publications

37 publications found
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]
TBCEL-TECTA (HGNC:54857): (TBCEL-TECTA readthrough) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015909076).
BP6
Variant 11-121130065-T-C is Benign according to our data. Variant chr11-121130065-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.223 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECTANM_005422.4 linkc.2795T>C p.Val932Ala missense_variant Exon 10 of 24 ENST00000392793.6 NP_005413.2
TBCEL-TECTANM_001378761.1 linkc.3752T>C p.Val1251Ala missense_variant Exon 16 of 30 NP_001365690.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECTAENST00000392793.6 linkc.2795T>C p.Val932Ala missense_variant Exon 10 of 24 5 NM_005422.4 ENSP00000376543.1
TECTAENST00000264037.2 linkc.2795T>C p.Val932Ala missense_variant Exon 9 of 23 1 ENSP00000264037.2
TECTAENST00000642222.1 linkc.2795T>C p.Val932Ala missense_variant Exon 10 of 24 ENSP00000493855.1
TECTAENST00000645008.1 linkc.101T>C p.Val34Ala missense_variant Exon 1 of 15 ENSP00000496274.1

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31090
AN:
152012
Hom.:
3230
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.172
Gnomad AMI
AF:
0.107
Gnomad AMR
AF:
0.204
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.234
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.243
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.219
Gnomad OTH
AF:
0.189
GnomAD2 exomes
AF:
0.217
AC:
54409
AN:
251140
AF XY:
0.215
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.231
Gnomad ASJ exome
AF:
0.212
Gnomad EAS exome
AF:
0.245
Gnomad FIN exome
AF:
0.247
Gnomad NFE exome
AF:
0.213
Gnomad OTH exome
AF:
0.213
GnomAD4 exome
AF:
0.220
AC:
322267
AN:
1461748
Hom.:
36052
Cov.:
38
AF XY:
0.220
AC XY:
159741
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.174
AC:
5809
AN:
33478
American (AMR)
AF:
0.229
AC:
10229
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5631
AN:
26134
East Asian (EAS)
AF:
0.268
AC:
10633
AN:
39700
South Asian (SAS)
AF:
0.201
AC:
17322
AN:
86256
European-Finnish (FIN)
AF:
0.247
AC:
13164
AN:
53336
Middle Eastern (MID)
AF:
0.176
AC:
1012
AN:
5766
European-Non Finnish (NFE)
AF:
0.221
AC:
245730
AN:
1111972
Other (OTH)
AF:
0.211
AC:
12737
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
16773
33545
50318
67090
83863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8512
17024
25536
34048
42560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.204
AC:
31091
AN:
152130
Hom.:
3231
Cov.:
33
AF XY:
0.204
AC XY:
15171
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.171
AC:
7114
AN:
41512
American (AMR)
AF:
0.204
AC:
3126
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
732
AN:
3472
East Asian (EAS)
AF:
0.234
AC:
1213
AN:
5174
South Asian (SAS)
AF:
0.190
AC:
916
AN:
4822
European-Finnish (FIN)
AF:
0.243
AC:
2572
AN:
10580
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.219
AC:
14866
AN:
67968
Other (OTH)
AF:
0.190
AC:
401
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1304
2609
3913
5218
6522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.214
Hom.:
14307
Bravo
AF:
0.202
TwinsUK
AF:
0.221
AC:
820
ALSPAC
AF:
0.224
AC:
865
ESP6500AA
AF:
0.175
AC:
771
ESP6500EA
AF:
0.210
AC:
1809
ExAC
AF:
0.214
AC:
25963
Asia WGS
AF:
0.213
AC:
740
AN:
3478
EpiCase
AF:
0.203
EpiControl
AF:
0.196

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val932Ala in Exon 09 of TECTA: This variant is not expected to have clinical sig nificance because it has been identified in 21.0% (1477/7020) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs520805).

Dec 16, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal recessive nonsyndromic hearing loss 21 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal dominant nonsyndromic hearing loss 12 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
17
DANN
Benign
0.63
DEOGEN2
Benign
0.11
T;.;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.061
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.0
.;T;T
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.92
L;.;L
PhyloP100
3.0
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
0.30
N;.;N
REVEL
Benign
0.12
Sift
Benign
0.54
T;.;T
Sift4G
Benign
0.73
T;.;T
Vest4
0.055
ClinPred
0.0050
T
GERP RS
4.7
PromoterAI
-0.14
Neutral
Varity_R
0.081
gMVP
0.71
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs520805; hg19: chr11-121000774; COSMIC: COSV50688374; API